ABBV-744 AS A POTENTIAL THERAPEUTIC OPTION FOR AGGRESSIVE CANCERS SECRETS

RUNX1 is a learn transcription aspect that regulates the expression of several genes necessary for hematopoiesis. Studies implied which the RUNX188 These preclinical studies deliver paradigms for long term clinical trials in AML, and the use of novel combinations of drugs is presently currently being investigated in clinical trials.Phase 1: Researc